EV-D68 adenovector-based vaccine (GenVec)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameEV-D68 adenovector-based vaccine (GenVec)

Drug Alias Nameadenoviral vector-based vaccine (GenVec)

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Recombinant vector vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsEnterovirus Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesGenVec Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesGenVec Inc

Active IndicationsN/A

Inactive IndicationsEnterovirus Infections

Other Information

ATC CodeN/A